Multiple Sclerosis Market Size, Share & Trends Analysis Report By Drug Type (Immunomodulatory, Immunosuppressant, Interferons, Corticosteroids), By Route of Administration (Oral, Parenteral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
  7. North America Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  8. Europe Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  9. APAC Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  10. Middle East and Africa Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  11. LATAM Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  12. Competitive Landscape
    1. Multiple Sclerosis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Biogen Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Sanofi
    3. GlaxoSmithKline plc.
    4. Celgene Corporation
    5. Pfizer Inc. 
    6. Novartis AG
    7. Teva Pharmaceuticals
    8. Synthetic Biologics Inc.
    9. Bayer AG
    10. Serono Inc.
    11. EMD Opexa Therapeutics Inc.
    12. Active Biotech AB
    13. Merck and Co.
    14. Actelion Pharmaceuticals Ltd.
    15. Innate Immunotherapeutics
    16. InnoBioscience LLC
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Multiple Sclerosis Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 3: Global Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 4: North America Multiple Sclerosis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 6: North America Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 7: U.S. Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 8: U.S. Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 9: Canada Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Canada Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 11: Europe Multiple Sclerosis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 13: Europe Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 14: U.K. Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 15: U.K. Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 16: Germany Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 17: Germany Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 18: France Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 19: France Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 20: Spain Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 21: Spain Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 22: Italy Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 23: Italy Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 24: Russia Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 25: Russia Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 26: Nordic Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 27: Nordic Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 28: Benelux Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 29: Benelux Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 30: Rest of Europe Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 31: Rest of Europe Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 32: APAC Multiple Sclerosis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 34: APAC Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 35: China Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 36: China Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 37: Korea Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 38: Korea Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 39: Japan Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 40: Japan Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 41: India Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 42: India Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 43: Australia Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 44: Australia Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 45: Singapore Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 46: Singapore Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 47: Taiwan Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 48: Taiwan Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 49: South East Asia Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 50: South East Asia Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 51: Rest of Asia-Pacific Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 52: Rest of Asia-Pacific Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Multiple Sclerosis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 54: Middle East and Africa Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 55: Middle East and Africa Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 56: UAE Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 57: UAE Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 58: Turkey Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 59: Turkey Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 60: Saudi Arabia Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 61: Saudi Arabia Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 62: South Africa Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 63: South Africa Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 64: Egypt Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 65: Egypt Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 66: Nigeria Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 67: Nigeria Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 68: Rest of MEA Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 69: Rest of MEA Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 70: LATAM Multiple Sclerosis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 71: LATAM Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 72: LATAM Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 73: Brazil Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 74: Brazil Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 75: Mexico Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 76: Mexico Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 77: Argentina Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 78: Argentina Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 79: Chile Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 80: Chile Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 81: Colombia Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 82: Colombia Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 83: Rest of LATAM Multiple Sclerosis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 84: Rest of LATAM Multiple Sclerosis Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

We are featured on: